Micro RNA-133a(mi RNA-133a) and cardiac troponin I(c Tn I) are different-type crucial biomarkers of acute myocardial infarction(AMI), whose levels are great significance for AMI diagnosis and treatment. Herein,a novel...Micro RNA-133a(mi RNA-133a) and cardiac troponin I(c Tn I) are different-type crucial biomarkers of acute myocardial infarction(AMI), whose levels are great significance for AMI diagnosis and treatment. Herein,a novel photoelectrochemical-electrochemical(PEC-EC) dual-mode biosensing platform for dual-target assays of mi RNA-133a and c Tn I was developed. In which, a PEC-EC dual-mode sensing platform for mi RNA-133a was constructed based on the changes of the photocurrent inhibition effect and the electrochemical signal of Fc on the Fc-hairpin DNA probe(Fc-HP)/Zn Cd S-quantum dots(QDs)/ITO electrode. Furthermore, under magnetic separation and the specific interaction between c Tn I and its aptamer, the N-doped porous carbon-Zn O polyhedra(NPC-Zn O)-hemin-capture DNA probe hybrid(NH-CP) was obtained and introduced to the Fc-HP/Zn Cd S-QDs/ITO electrode via hybridization between NH-CP and Fc-HP. The hemin molecules encapsulated in NH-CP could effectively induce the photocurrent-polarity-switching of the FcHP/Zn Cd S-QDs/ITO electrode and generate a new electrochemical signal originating from hemin. Thus,c Tn I was assayed sensitively and selectively by the PEC-EC dual-mode biosensing platform. Here, Fc and hemin not only serve as the electrochemical indicators, but also respectively inhibit the photocurrent and switch the photocurrent polarity of Zn Cd S-QDs. Furthermore, the proposed biosensing platform could be easily expanded to the detection of other multiplex-type biomarkers via the change of the sequences of the related DNA probes, implying its significant potential in clinical diagnosis and biological analysis.展开更多
基金financially supported by National Natural Science Foundation of China (Nos. 22074033, 22374035)。
文摘Micro RNA-133a(mi RNA-133a) and cardiac troponin I(c Tn I) are different-type crucial biomarkers of acute myocardial infarction(AMI), whose levels are great significance for AMI diagnosis and treatment. Herein,a novel photoelectrochemical-electrochemical(PEC-EC) dual-mode biosensing platform for dual-target assays of mi RNA-133a and c Tn I was developed. In which, a PEC-EC dual-mode sensing platform for mi RNA-133a was constructed based on the changes of the photocurrent inhibition effect and the electrochemical signal of Fc on the Fc-hairpin DNA probe(Fc-HP)/Zn Cd S-quantum dots(QDs)/ITO electrode. Furthermore, under magnetic separation and the specific interaction between c Tn I and its aptamer, the N-doped porous carbon-Zn O polyhedra(NPC-Zn O)-hemin-capture DNA probe hybrid(NH-CP) was obtained and introduced to the Fc-HP/Zn Cd S-QDs/ITO electrode via hybridization between NH-CP and Fc-HP. The hemin molecules encapsulated in NH-CP could effectively induce the photocurrent-polarity-switching of the FcHP/Zn Cd S-QDs/ITO electrode and generate a new electrochemical signal originating from hemin. Thus,c Tn I was assayed sensitively and selectively by the PEC-EC dual-mode biosensing platform. Here, Fc and hemin not only serve as the electrochemical indicators, but also respectively inhibit the photocurrent and switch the photocurrent polarity of Zn Cd S-QDs. Furthermore, the proposed biosensing platform could be easily expanded to the detection of other multiplex-type biomarkers via the change of the sequences of the related DNA probes, implying its significant potential in clinical diagnosis and biological analysis.
